Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 28.04 crore in the quarter ended June 2024 as against net loss of Rs 24.09 crore during the previous quarter ended June 2023. Sales declined 73.42% to Rs 1.01 crore in the quarter ended June 2024 as against Rs 3.80 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1.013.80 -73 OPM %-3023.76-737.11 - PBDT-26.55-22.43 -18 PBT-28.04-24.09 -16 NP-28.04-24.09 -16 Powered by Capital Market - Live News

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live News

Suven Life Sciences announced that the 35th Annual General Meeting(AGM) of the company will be held on 2 August 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 26.54 crore in the quarter ended March 2024 as against net loss of Rs 27.64 crore during the previous quarter ended March 2023. Sales declined 8.43% to Rs 2.39 crore in the quarter ended March 2024 as against Rs 2.61 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 105.08 crore in the year ended March 2024 as against net loss of Rs 118.27 crore during the previous year ended March 2023. Sales declined 13.66% to Rs 11.69 crore in the year ended March 2024 as against Rs 13.54 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2.392.61 -8 11.6913.54 -14 OPM %-1266.95-1207.66 --1095.04-929.76 - PBDT-26.03-25.97 0 -107.04-117.72 9 PBT-27.54-27.64 0 -113.54-124.27 9 NP-26.54-27.64 4 -105.08-118.27 11 Powered by Capital Market - Live News